Faus Moliner participa en “International Comparative Legal Guide – Drug & Medical Device Litigation 2024”
Xavier Moliner and Juan Martínez write the chapter related to Drug & Medical Device Litigation in Spain
INTERNATIONAL COMPARATIVE LEGAL GUIDE
The 2024 edition of the International International Comparative Legal Guide to Drug & Medical Device Litigation magazine is now available. The Guide offers a practical insight into drug and medical devices litigation issues across the world. Xavier Moliner and Juan Martinez were in charge of chapter 15 dedicated to drug and medical device litigation.
Faus Moliner participates in “Chambers Global Practices Guides – Life Sciences 2024”
Joan Carles Bailach, Anna Gerbolés, Claudia Gonzalo and Juan Martínez write the chapter about Spain
Chambers Global Practices Guides
The Life Sciences 2024 guide features over 20 jurisdictions. The guide provides the latest legal information on challenging the decisions of regulatory bodies; clinical trials; the marketing, manufacturing and distribution of pharmaceuticals and medical devices; pricing; digital healthcare; patents; and developments related to COVID-19.
Vientos de cambio en las normas sobre publicidad
El Global
El régimen de la publicidad de medicamentos se encuentra regulado, en cuanto a sus bases, en la normativa europea, concretamente en la Directiva 2001/83/CE en el caso de los medicamentos de uso humano, y en el Reglamento 2019/6, que derogó la antigua Directiva 2001/82/CE, cuando se trata de medicamentos veterinarios. Luego es cada Estado Miembro... Read More
Faus Moliner, ranked in Band 1 for Life Sciences in the Chambers Europe 2024 Guide
Chambers & Partners has published the 2024 edition of the Chambers Europe Guide and Faus Moliner has once again obtained the highest possible recognition.
The Chambers Europe Guide is a prestigious publication. The rankings are the result of extensive research conducted by its in-house research team, which conducts interviews with in-house counsel, other third-party experts and private practice lawyers. The Guide has been publishing independent rankings of law firms for 18 years and Faus Moliner has since the beginning... Read More
Faus & Moliner participates in the “Chambers Global Practices Guides – Pharmaceutical Advertising 2024”
Anna Gerbolés y Laia Rull write the chapter about Law and Practice in Spain
The “Law & Practice” section provides easily accessible information on navigating the legal system when conducting business in the jurisdiction. Leading lawyers explain local law and practice at key transactional stages and for crucial aspects of doing business. The “Trends and Developments” section analizes the latest trends and developments in connection with pharmaceutical advertising in... Read More
Plan Anual Normativo 2024
El Global
El pasado 26 de marzo, el Consejo de Ministros aprobó el Plan Anual Normativo (PAN) del Gobierno para el año 2024. El PAN es un documento que incluye las iniciativas legislativas o reglamentarias que los distintos ministerios prevén elevar durante dicho año natural al Consejo de Ministros para su aprobación, con una descripción breve de... Read More
Faus Moliner is recognized once more in the 2024 Edition of The Legal 500 (Legalease)
Faus Moliner appears in Tier 1 in the area of Healthcare and Life Sciences
This year Jordi Faus is in the Hall of Fame and Xavier Moliner continues to appear as leading individual, while Lluís Alcover has been identified as a key lawyer of our firm. Those interviewed by The Legal 500 highlight that Faus Moliner is “a specialized law firm with which we have collaborated successfully for many... Read More
Faus & Moliner participates in «The Legal 500: Product Liability Country Comparative Guides»
Xavier Moliner and Juan Martínez write the chapter regarding product liability in Spain
The Legal 500 Comparative Guides
The aim of this guide is to provide its readers with a general overview of current Product Liability laws and regulations in each of the jurisdictions to which it refers. Each chapter of this guide provides information about objective product liability, non-contractual and contract liability and litigation that can be raised on these matters. Xavier Moliner... Read More
A favor de la colaboración público-privada
El Global
Cualquier iniciativa de colaboración público-privada para la investigación, desarrollo y posterior comercialización de medicamentos es una buena noticia. Buena no, buenísima. La Ley 9/2017 de Contratos del Sector Público, en su día, suprimió la figura del contrato de colaboración público privada. En la Exposición de Motivos de la Ley se justificaba esta supresión haciendo referencia... Read More
Faus Moliner participates at the Course on Pharmaceutical Law organized by CEFI
Lluís Alcover, Joan Carles Bailach and Jordi Faus participated at the Course on Pharmaceutical Law "Biomedicine, Medicines and Public Health" organized by the CEFI Foundation.
In recent years, the Course on Pharmaceutical Law organized by the CEFI Foundation has established itself as a reference forum for the legal analysis of the various issues that arise during the life of a drug. In this latest edition, held in Madrid on 05 and 06 March 2024, Faus Moliner has participated with three... Read More